STAT3 mutations are present in aggressive B-cell lymphomas including a subset of diffuse large B-cell lymphomas with CD30 expression.
Stanford University Medical Center, Stanford CA, USA rohgami@stanford.edu.
Robert S
RS
Ohgami
Stanford University Medical Center, Stanford CA, USA.
Lisa
L
Ma
Oncology, Hematology and Pathology, Shiraz University, Pathology, Iran.
Ahmad
A
Monabati
Stanford University Medical Center, Stanford CA, USA.
James L
JL
Zehnder
Stanford University Medical Center, Stanford CA, USA.
Daniel A
DA
Arber
D000818:Animals; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D004195:Disease Models, Animal; D019337:Hematologic Neoplasms / Q000235:genetics*; D006801:Humans; D009154:Mutation / Q000235:genetics*; D009196:Myeloproliferative Disorders / Q000235:genetics*; D050796:STAT3 Transcription Factor / Q000235:genetics*
D050796:STAT3 Transcription Factor
B-cell lymphoma unclassifiable with features intermediate between DLBCL and Burkitt lymphoma; CD30; STAT3; anaplastic large cell lymphoma; diffuse large B-cell lymphoma